SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SPRC SciSparc Ltd.

Closed 08-10 16:00:00 EDT

6.61

-0.32

-4.62%

盘后6.61

+0.000.00%

19:34 EDT

High7.06	Low6.50	Vol25.12K
Open7.06	D1 Closing6.93	Amplitude8.08%
Mkt Cap3.79M	Tradable Cap3.21M	Total Shares573.24K
T/O167.45K	T/O Rate5.18%	Tradable Shares485.10K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SPRC","market":"US","secType":"STK","nameCN":"SciSparc Ltd.","latestPrice":6.61,"timestamp":1786392000000,"preClose":6.93,"halted":0,"volume":25118,"hourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.61,"latestTime":"19:34 EDT","volume":281,"amount":1817.2341,"timestamp":1786404851414,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04617604617604609,"floatShares":485100,"shares":573243,"eps":-98.07143,"marketStatus":"Closed","change":-0.32,"latestTime":"08-10 16:00:00 EDT","open":7.06,"high":7.06,"low":6.5,"amount":167449.64936,"amplitude":0.080808,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-98.07143,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1786435200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":6.93,"preHourTrading":{"tag":"盘前","latestPrice":6.74,"preClose":6.93,"latestTime":"09:19 EDT","volume":157,"amount":1057.0344809,"timestamp":1786367976277,"change":-0.19,"changeRate":-0.027417,"amplitude":0.012973},"postHourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.61,"latestTime":"19:34 EDT","volume":281,"amount":1817.2341,"timestamp":1786404851414,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.583591},"requestUrl":"/m/hq/s/SPRC","defaultTab":"news","newsList":[{"id":"2657544402","title":"SciSparc Subsidiary NeuroThera Launches Phase IIb Tourette Trial Site at Yale Child Study Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544402","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544402?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:22","pubTimestamp":1785932541,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera launches Phase IIb Tourette trial site at Yale Child Study CenterSciSparc subsidiary NeuroThera Labs launched a U.S. Phase IIb trial site at Yale for SCI-110 in adult To","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL6B19Rb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4585","LU2095319765.USD","IE00BN0W2W23.USD","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4007","BCDF","SG9999014005.SGD","NDAQ","BK4139","IE00BGHQF748.EUR","BK4112","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SPRC","LU2210149790.SGD","BK4588","SG9999014021.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544403","title":"Scisparc: Subsidiary Neurothera Labs Launches Phase Iib Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544403?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:22","pubTimestamp":1785932520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA2VCJMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655999366","title":"SciSparc Subsidiary NeuroThera Labs’ Quantum Platform Completes End-to-end Hybrid Workflow for Clinical Data Analytics","url":"https://stock-news.laohu8.com/highlight/detail?id=2655999366","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655999366?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:20","pubTimestamp":1785500414,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera Labs’ quantum platform completes end-to-end hybrid workflow for clinical data analyticsSciSparc unit NeuroThera reached a milestone in its quantum sampling platform for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL8LM4q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014039.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","BK4007","IE00B3QW5Z07.USD","BK4139","BK4588","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","SG9999014021.USD","SPRC","BCDF","IE00BN0W2W23.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655899352","title":"NASDAQ Trade Halt Volatility Trading Pause at 10:22 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2655899352","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655899352?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:22","pubTimestamp":1785334926,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 10:22 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nAQN2MC6MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655945896","title":"Scisparc Ltd trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2655945896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655945896?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:56","pubTimestamp":1785333362,"startTime":"0","endTime":"0","summary":"09:53 EDT Scisparc (SPRC)Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-ltd-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-ltd-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JULD","BK4007","RSEE","SPRC","QQQP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655251893","title":"SciSparc Targets Agentic AI Market as New Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2655251893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655251893?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:12","pubTimestamp":1785330744,"startTime":"0","endTime":"0","summary":"SciSparc targets agentic AI market as new growth strategySciSparc shifted strategy to target the agentic AI market.Plans include forming a Scientific Advisory Board focused on artificial intelligence,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4Bfrtd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655898511","title":"SciSparc Subsidiary NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Trials Analytics Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2655898511","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655898511?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:35","pubTimestamp":1785328511,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera Labs validates quantum sampling workflow for clinical trials analytics platformSciSparc unit NeuroThera Labs completed internal validation of a proprietary quantum sampl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL2JkDjl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4007","LU2210149790.SGD","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","LU2095319765.USD","BCDF","BK4588","SPRC","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4585","NDAQ","IE00B64PRP62.GBP","BK4112","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654513010","title":"Scisparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity","url":"https://stock-news.laohu8.com/highlight/detail?id=2654513010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654513010?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:25","pubTimestamp":1785155109,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43T113:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010514","title":"Scisparc - in Discussions with Companies in Agentic AI Field","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010514?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:25","pubTimestamp":1785155109,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43T113:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651546659","title":"SciSparc initiates SCI-110 clinical trial in Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2651546659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651546659?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:06","pubTimestamp":1784120761,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced that its subsidiary NeuroThera Labs announced the initiation of its Phase IIb clinical trial site at Hannover Medical Scho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-initiates-sci-110-clinical-trial-in-germany-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-initiates-sci-110-clinical-trial-in-germany-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","MEDX","SPRC","BK4007","BK4139","IDNA","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651634904","title":"Scisparc: Neurothera Labs Announces Initiation of Phase Iib Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2651634904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651634904?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:41","pubTimestamp":1784119303,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651546310","title":"Scisparc Unit Neurothera Labs Starts Phase Iib Tourette Trial Site at Hannover Medical School","url":"https://stock-news.laohu8.com/highlight/detail?id=2651546310","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651546310?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:41","pubTimestamp":1784119277,"startTime":"0","endTime":"0","summary":"SciSparc unit NeuroThera Labs starts Phase IIb Tourette trial site at Hannover Medical SchoolSciSparc unit NeuroThera Labs initiated a Phase IIb clinical trial site at Hannover Medical School for SCI-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL1kXf46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","LU2095319765.USD","IE00BN0W2W23.USD","BK4007","BCDF","SG9999014039.USD","LU2210149790.SGD","SG9999014013.SGD","NDAQ","BK4139","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","BK4112","IE00BKPKM429.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648560559","title":"Neurothera Labs Targets up to C$ 5 Million in Private Placement of Units at C$ 0.135 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2648560559","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648560559?lang=en_us&edition=fundamental","pubTime":"2026-07-01 06:00","pubTimestamp":1782856824,"startTime":"0","endTime":"0","summary":"NeuroThera Labs targets up to C$ 5 million in private placement of units at C$ 0.135 eachNeuroThera Labs launched a non-brokered private placement of up to 37,050,000 units at C$ 0.14 each to raise up","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL82lYdG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPRC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640615477","title":"SciSparc unit NeuroThera closes purchase of 54% stake in CliniQuantum for CAD 9.46 million in shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2640615477","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640615477?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:36","pubTimestamp":1780572986,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera Labs closed its purchase of about 54% of Israel-based CliniQuantum.NeuroThera issued 56,600,000 common shares valued at about CAD 9.46 million to acquire 56,375 CliniQuantum shares.Sellers can earn up to USD 2.5 million over three years, tied to patent filings and fundraising milestones.CliniQuantum develops quantum-based analytics for clinical trial data, aiming to identify patient subgroups that respond to therapies.Key asset is an exclusive worldwide license from Quantum X Labs covering a US provisional patent application in quantum Monte Carlo sampling.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief on June 04, 2026, and is ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL8zH0F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4009","QXL","BK4139","SPRC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640154738","title":"Scisparc: Subsidiary Neurothera Labs Completed Acquisition of Cliniquantum","url":"https://stock-news.laohu8.com/highlight/detail?id=2640154738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640154738?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:32","pubTimestamp":1780572720,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA2FT8YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901635","title":"SciSparc director Itschak Shrem sells 462 shares for $4,620","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901635","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901635?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:00","pubTimestamp":1780488058,"startTime":"0","endTime":"0","summary":"SciSparc director Itschak Shrem sold 462 ordinary shares on June 1 at USD 10.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL3Dfqr1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SciSparc director Itschak Shrem sells 462 shares for $4,620","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639690209","title":"BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's","url":"https://stock-news.laohu8.com/highlight/detail?id=2639690209","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639690209?lang=en_us&edition=fundamental","pubTime":"2026-05-29 01:41","pubTimestamp":1779990094,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl'sWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL6N4250NZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZCMD","HL","INKT","NEBX","MOD","AVEX","BTU","NEMG","NEM","TSN","PLAB","NEOV","SIDU","DAVE","DLTR","HPQ","SUGP","SNOW","MRVL","SNOU","MMM","CZR","AMPX","CGTL","LLY","D","NSC","SPRC","CDE","A","CVX","NEE","BBY","HRL","NBIS","XOM","AU","SNPS","APA","UMAC","UNP","KSS","MASK","CRM","BURL","COGT","PWR","HLXX","FANG","P"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697490","title":"Why Is SciSparc Stock Skyrocketing On Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697490","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697490?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:28","pubTimestamp":1779985680,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.  stock is surging on Thursday. The Nasdaq is up 0.63% while the S&P 500 has gained 0.41%.The massive upside comes on the heels of a pre-market announcement detailing a key regulatory milestone achieved by the Tel Aviv-based pharmaceutical player’s majority-owned subsidiary.SciSparc stock is showing exceptional strength. What’s driving SPRC stock higher?SciSparc announced that its subsidiary, NeuroThera Labs Inc., received conditional regulatory approval from the TSX Venture Exchange. The approval clears a path for NeuroThera to acquire an approximate 54% majority stake in CliniQuantum Ltd.Under the terms of the share purchase agreement  previously disclosed in March, NeuroThera will acquire 56,375 ordinary shares of CliniQuantum. In exchange, NeuroThera will issue 56.600 million common shares to the selling shareholders, representing an aggregate value of approximately $9.459 million.CliniQuantum, a private Israeli technology company, develops a platform that applies quan","market":"us","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=630,dpr=2,format=auto,quality=85/files/images/story/2026/05/28/Man-Hand-With-Stock-Market-Graph-With-Ro_0.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=630,dpr=2,format=auto,quality=85/files/images/story/2026/05/28/Man-Hand-With-Stock-Market-Graph-With-Ro_0.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/05/52847602/why-is-scisparc-stock-skyrocketing-on-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/05/52847602/why-is-scisparc-stock-skyrocketing-on-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["SPRC","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638169670","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2638169670","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638169670?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:30","pubTimestamp":1779975047,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nAQN2M0WXI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPRC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638693005","title":"SciSparc unit NeuroThera wins conditional TSX approval for CliniQuantum acquisition update","url":"https://stock-news.laohu8.com/highlight/detail?id=2638693005","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638693005?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:40","pubTimestamp":1779972014,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera Labs received conditional TSX Venture Exchange clearance to buy about 54% of CliniQuantum.NeuroThera plans to issue 56,600,000 common shares valued at about $9.46 million to acquire 56,375 CliniQuantum shares.The deal’s outside date was extended to June 1, 2026, pending an Israeli tax ruling and final TSX acceptance.Earn-out shares will be priced at no less than $0.05 each, with a floor price and seller lock-ups added to the terms.All 56,600,000 consideration shares will be placed in escrow under a Form 5D escrow agreement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL2J4Lrf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4588","LU2210150020.SGD","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","SPRC","SG9999014013.SGD","BK4585","BK4112","IE00B64PRP62.GBP","BK4139","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4007","LU0314104364.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scisparc.com","stockEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":0.2623},{"period":"3month","weight":0.1088},{"period":"6month","weight":0.1257},{"period":"1year","weight":-0.8547},{"period":"ytd","weight":-0.4338}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.075328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.14034},{"month":3,"riseRate":0,"avgChangeRate":-0.320237},{"month":4,"riseRate":0.4,"avgChangeRate":0.283936},{"month":5,"riseRate":0.6,"avgChangeRate":-0.008039},{"month":6,"riseRate":0,"avgChangeRate":-0.212405},{"month":7,"riseRate":0.2,"avgChangeRate":-0.13712},{"month":8,"riseRate":0,"avgChangeRate":-0.379291},{"month":9,"riseRate":0.25,"avgChangeRate":0.236982},{"month":10,"riseRate":0.75,"avgChangeRate":0.077569},{"month":11,"riseRate":0.5,"avgChangeRate":0.007929},{"month":12,"riseRate":0.25,"avgChangeRate":-0.09099}],"exchange":"NASDAQ","name":"SciSparc Ltd.","nameEN":"SciSparc Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SciSparc Ltd.(SPRC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SciSparc Ltd.,SPRC,SciSparc Ltd.股票,SciSparc Ltd.股票老虎,SciSparc Ltd.股票老虎国际,SciSparc Ltd.行情,SciSparc Ltd.股票行情,SciSparc Ltd.股价,SciSparc Ltd.股市,SciSparc Ltd.股票价格,SciSparc Ltd.股票交易,SciSparc Ltd.股票购买,SciSparc Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SciSparc Ltd.(SPRC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction